Successful treatment of multifocal cutaneous leishmaniasis with miltefosine
- PMID: 22121288
- PMCID: PMC3221233
- DOI: 10.4103/0019-5154.87165
Successful treatment of multifocal cutaneous leishmaniasis with miltefosine
Abstract
We report a 48-year-old immunocompetent male, resident of Central India, who presented with slowly progressive asymptomatic multiple red lesions on different parts of body. On enquiry, the patient gave history of travel to Middle East 6 months back. Examination showed 10 crusted erythematous indurated plaques and nodules over forearms, left leg, right index finger, left wrist and dorsa of both feet. Histopathological examination of tissue biopsy showed multiple intracellular as well as extracellular leishmania donovan bodies. Keeping in mind the higher rate of side effects to pentavalent antimony, we treated this patient with oral miltefosine 50 mg bid and the lesions showed complete resolution over 4 months of therapy.
Keywords: Leishmaniasis; miltefosine; multifocal.
Conflict of interest statement
Figures






Similar articles
-
Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.PLoS Negl Trop Dis. 2015 Feb 13;9(2):e0003556. doi: 10.1371/journal.pntd.0003556. eCollection 2015 Feb. PLoS Negl Trop Dis. 2015. PMID: 25679212 Free PMC article.
-
Searching for cutaneous leishmaniasis in tribals from kerala, India.J Glob Infect Dis. 2010 May;2(2):95-100. doi: 10.4103/0974-777X.62874. J Glob Infect Dis. 2010. PMID: 20606960 Free PMC article.
-
Relapse of new world diffuse cutaneous leishmaniasis caused by Leishmania (Leishmania) mexicana after miltefosine treatment.Am J Trop Med Hyg. 2006 Dec;75(6):1074-7. Am J Trop Med Hyg. 2006. PMID: 17172368
-
Advances in the treatment of leishmaniasis.Curr Opin Infect Dis. 2002 Dec;15(6):593-8. doi: 10.1097/00001432-200212000-00007. Curr Opin Infect Dis. 2002. PMID: 12821836 Review.
-
Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.J Antimicrob Chemother. 2012 Nov;67(11):2576-97. doi: 10.1093/jac/dks275. Epub 2012 Jul 24. J Antimicrob Chemother. 2012. PMID: 22833634 Review.
Cited by
-
Cutaneous Leishmaniasis in a Nonendemic Area of South Rajasthan: A Prospective Study.Indian J Dermatol. 2016 Sep-Oct;61(5):521-4. doi: 10.4103/0019-5154.190117. Indian J Dermatol. 2016. PMID: 27688441 Free PMC article.
-
Non-Endemic Leishmaniases Reported Globally in Humans between 2000 and 2021-A Comprehensive Review.Pathogens. 2022 Aug 16;11(8):921. doi: 10.3390/pathogens11080921. Pathogens. 2022. PMID: 36015042 Free PMC article. Review.
-
Lupoid leishmaniasis successfully treated with oral fluconazole in a child.Med J Armed Forces India. 2024 Dec;80(Suppl 1):S368-S370. doi: 10.1016/j.mjafi.2022.12.014. Epub 2023 Jan 30. Med J Armed Forces India. 2024. PMID: 39734889 No abstract available.
References
-
- Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol. 2007;25:203–11. - PubMed
-
- Wright NA, Davis LE, Aftergut KS, Parrish CA, Cockerell CJ. Cutaneous leishmaniasis in Texas: A northern spread of endemic areas. J Am Acad Dermatol. 2008;58:650–2. - PubMed
-
- Guerin PJ, Olliaro P, Sundar S, Boelaert M, Croft SL, Desjeux P, et al. Visceral leishmaniasis: Current status of control, diagnosis, and treatment, and a proposed research and development agenda. Lancet Infect Dis. 2002;2:494–501. - PubMed
-
- Herwaldt B. Leishmaniasis. Lancet. 1999;354:1191–9. - PubMed
-
- Soto J, Soto P. Miltefosine: Oral treatment of leishmaniasis. Expert Rev Anti Infect Ther. 2006;4:177–85. - PubMed
LinkOut - more resources
Full Text Sources